DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DMP - DE000A2GS5D8 - Common Stock
38.3 EUR
-0.25 (-0.65%)
DMP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. DMP has only an average score on both its financial health and profitability. DMP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
DMP had positive earnings in the past year.
In the past year DMP had a positive cash flow from operations.
Each year in the past 5 years DMP has been profitable.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 5.48%, DMP perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
DMP has a Return On Equity of 17.87%. This is in the better half of the industry: DMP outperforms 61.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.26%, DMP is in line with its industry, outperforming 47.27% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DMP is below the industry average of 13.65%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROIC | 7.26% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP has a Profit Margin (10.00%) which is comparable to the rest of the industry.
DMP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 18.70%, DMP is in line with its industry, outperforming 50.91% of the companies in the same industry.
DMP's Operating Margin has improved in the last couple of years.
The Gross Margin of DMP (66.57%) is worse than 60.00% of its industry peers.
In the last couple of years the Gross Margin of DMP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DMP is still creating some value.
The number of shares outstanding for DMP remains at a similar level compared to 1 year ago.
The number of shares outstanding for DMP remains at a similar level compared to 5 years ago.
The debt/assets ratio for DMP is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.26 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.26, DMP is in line with its industry, outperforming 45.45% of the companies in the same industry.
DMP has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as DMP would need 6.15 years to pay back of all of its debts.
The Debt to FCF ratio of DMP (6.15) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DMP has dependencies on debt financing.
The Debt to Equity ratio of DMP (1.44) is worse than 76.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 2.26 |
ROIC/WACC1.16
WACC6.27%
2.3 Liquidity
A Current Ratio of 2.20 indicates that DMP has no problem at all paying its short term obligations.
DMP's Current ratio of 2.20 is fine compared to the rest of the industry. DMP outperforms 74.55% of its industry peers.
DMP has a Quick Ratio of 1.04. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.04, DMP is doing good in the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
DMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.01%, which is quite impressive.
Measured over the past years, DMP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.07% on average per year.
The Revenue has been growing slightly by 0.11% in the past year.
Measured over the past years, DMP shows a quite strong growth in Revenue. The Revenue has been growing by 11.00% on average per year.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
3.2 Future
Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.68% on average per year.
Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 3.09% on average per year.
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.81, the valuation of DMP can be described as rather expensive.
DMP's Price/Earnings ratio is a bit cheaper when compared to the industry. DMP is cheaper than 61.82% of the companies in the same industry.
DMP is valuated rather cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.99, DMP is valued correctly.
Based on the Price/Forward Earnings ratio, DMP is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
DMP is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.81 | ||
| Fwd PE | 14.99 |
4.2 Price Multiples
80.00% of the companies in the same industry are more expensive than DMP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DMP is valued cheaper than 83.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.54 | ||
| EV/EBITDA | 9.7 |
4.3 Compensation for Growth
DMP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.41
PEG (5Y)2.21
EPS Next 2Y11.78%
EPS Next 3Y11.05%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.29%, DMP has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.60, DMP pays a bit more dividend than its industry peers.
DMP's Dividend Yield is comparable with the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.29% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
DMP pays out 41.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.76%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
FRA:DMP (1/5/2026, 2:53:00 PM)
38.3
-0.25 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners11.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.06B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (11.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.29% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.81 | ||
| Fwd PE | 14.99 | ||
| P/S | 1.78 | ||
| P/FCF | 12.54 | ||
| P/OCF | 9.98 | ||
| P/B | 3.18 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.7 |
EPS(TTM)2.15
EY5.61%
EPS(NY)2.56
Fwd EY6.67%
FCF(TTM)3.05
FCFY7.97%
OCF(TTM)3.84
OCFY10.02%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.41
PEG (5Y)2.21
Graham Number24.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROCE | 11.89% | ||
| ROIC | 7.26% | ||
| ROICexc | 7.91% | ||
| ROICexgc | 21.74% | ||
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% | ||
| FCFM | 14.17% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | 3.09 | ||
| Cap/Depr | 49.31% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 4.01 | ||
| Cash Conversion | 68.3% | ||
| Profit Quality | 141.71% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 2.26 |
F-Score7
WACC6.27%
ROIC/WACC1.16
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.22%
EBIT Next 3Y19.63%
EBIT Next 5Y7.73%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
Can you provide the valuation status for DERMAPHARM HOLDING SE?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.
What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.81 and the Price/Book (PB) ratio is 3.18.
Can you provide the expected EPS growth for DMP stock?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 12.59% in the next year.